Conrad Wai - 15 Jan 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO, Counterpart Health
Signature
/s/ Peter J. Rivas as attorney-in-fact for Conrad Wai
Issuer symbol
CLOV
Transactions as of
15 Jan 2026
Net transactions value
-$72,689
Form type
4
Filing time
20 Jan 2026, 17:46:04 UTC
Previous filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wai Conrad CEO, Counterpart Health C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai 20 Jan 2026 0001971702

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability $72,689 -25,868 -2.5% $2.81 1,025,806 15 Jan 2026 Direct F1
holding CLOV Class A Common Stock 1,610,482 15 Jan 2026 By Trust. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.